News
Swiss pharma giant Roche has announced positive Phase I/II data on NXT007 in people with hemophilia A, supporting its ...
Chugai Pharma presents positive data from NXTAGE phase I/II study of NXT007 in people with haemophilia A at ISTH 2025 Congress: Tokyo Tuesday, June 24, 2025, 13:00 Hrs [IST] Chuga ...
The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...
Positive phase I/II data presented at the 2025 International Society on Thrombosis and Haemostasis (ISTH) Congress show ...
CHICAGO, IL, USA I June 2, 2025 I ImmuneOncia Therapeutics, Inc. (CEO Heung-Tae Kim) announced interim results today from the ongoing Phase 1b clinical trial of its next-generation CD47-targeting ...
RAHWAY, NJ, USA I May 30, 2025 I Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the dose confirmation portion of the Phase 2/3 waveLINE-003 study ...
Tel Aviv, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon ...
Italian newspapers are reporting a historic moment in Franco-Italian economic relations: Italy is no longer the smaller partner. While Italy’s gross domestic product (GDP) reached only €2.19 trillion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results